F
Ford Motor Company
F lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
UCAR
U Power Limited
There isn't enough reported data to score UCAR yet.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
UCAR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
UCAR's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
UCAR PE Valuation
UCAR has no meaningful PE right now: it lost money over the past year.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
UCAR Forward outlook
There aren't enough analyst estimates for UCAR to show an outlook.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
UCAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$728.48 | -$273.46 |
| Q4 2025 | -$451.71 | +$52.23 |
UCAR has the edge over F in the latest year-over-year earnings comparison.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F's revenue grew through 2023 and has held roughly level since: $49.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F has the edge over UCAR on profitability, with a higher operating margin.
UCAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.2M | -17% |
| Q4 2025 | $3.5M | -25% |
| Q2 2025 | $2.7M | +34% |
| Q4 2024 | $4.7M | +74% |
| Q2 2024 | $2M | +596% |
| Q4 2023 | $2.7M | +129% |
| Q4 2022 | $1.2M | +95% |
| Q4 2021 | $601K | +447% |
UCAR has the edge over F in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -542% | -342 points |
| Q4 2025 | -174% | -83 points |
| Q2 2025 | -98% | +984 points |
| Q4 2024 | -102% | +620 points |
| Q2 2024 | -200% | +361 points |
| Q4 2023 | -92% | +470 points |
| Q2 2023 | -1083% | +11 points |
| Q4 2022 | -722% | +372 points |
UCAR's operating margin was −542% last quarter, down 342 points from the same quarter a year ago.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.
UCAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2022 | -$3.1M | +$3.9M |
| Q4 2021 | -$7M | -$5.2M |
| Q2 2021 | -$7M | -$5.2M |
UCAR and F do not have enough comparable growth data to identify a winner.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has the edge over UCAR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
UCAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +10% | +2.3K shares |
| 1 year | +59% | +9.3K shares |
UCAR has 25,148 diluted shares, up 59% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $36M |
| Q4 2021 | — |
| Q2 2021 | — |
| Q4 2020 | — |
| Q2 2020 | — |
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has more cash than debt.
UCAR Net Leverage
UCAR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
UCAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.5 | Oversold |
| Stochastic | 3.2 | Oversold |
UCAR's weekly RSI is 21 (oversold) and its Stochastic is 3 (oversold).
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
UCAR PE vs Consumer Cyclical Sector
UCAR has no meaningful PE right now: it lost money over the past year.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
UCAR has stronger trend alignment. F is above 0 of 5 weekly averages versus UCAR above 0 of 4.
UCAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 17% below |
| 20 week MA | $10.6 | 72% below |
| 50 week MA | $101.2 | 97% below |
| 100 week MA | $366.9 | 99% below |
UCAR is in a downtrend: it's below all four of its weekly moving averages, and 99% below its 100-week average.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F has the edge over UCAR on returns for 2026, with the stronger performance.
UCAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $156,600.0 | $3,670.0 | -98% |
| 2024 | $3,670.0 | $1,326.0 | -64% |
| 2025 | $1,326.0 | $338.0 | -75% |
| 2026 YTD | $338.0 | $2.93 | -99% |
UCAR has finished every year since 2023 lower, and it's down 99% so far in 2026.